ChemPartner PharmaTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	411.83	368.33	347.26	761.66	160.46
Trading Asset Securities	45.57	1.05	2.21	-	18.98
Cash & Short-Term Investments	457.39	369.37	349.47	761.66	179.44
Cash Growth	23.83%	5.70%	-54.12%	324.46%	-35.73%
Accounts Receivable	238.3	199.01	268.11	349.87	372.28
Other Receivables	6.91	12.06	12.01	87.18	8.49
Receivables	245.2	211.07	280.12	437.06	380.77
Inventory	9.47	11.44	27.88	42.82	68.81
Prepaid Expenses	-	0.87	11.03	-	-
Other Current Assets	52.95	51.31	58.68	38.82	58.72
Total Current Assets	765.02	644.07	727.18	1,280	687.74
Property, Plant & Equipment	617.45	683.88	851.39	973.62	1,512
Long-Term Investments	185.51	214.46	199.79	197.02	175.96
Goodwill	-	-	139.26	858.86	1,207
Other Intangible Assets	32.69	30.66	30.05	55.66	148.61
Long-Term Deferred Tax Assets	46.75	39.46	40.45	10.66	4.89
Long-Term Deferred Charges	238.13	267.09	324.36	370.23	385.02
Other Long-Term Assets	147.39	116.18	121.85	77.49	96.39
Total Assets	2,033	1,996	2,434	3,824	4,218
Accounts Payable	50.31	64.02	53.79	80.7	108.38
Accrued Expenses	48.92	58.19	82.78	100.26	90.66
Short-Term Debt	67.32	58.47	60	115.02	158.57
Current Portion of Long-Term Debt	67.91	6.52	4.3	111.47	330.13
Current Portion of Leases	-	73.98	69.63	67.24	72.83
Current Income Taxes Payable	6.54	4.61	5.42	49.85	8.6
Current Unearned Revenue	45.28	41.93	77.21	78.26	57.59
Other Current Liabilities	69.18	38.97	73.63	129.24	163.91
Total Current Liabilities	355.45	346.7	426.77	732.03	990.66
Long-Term Debt	28.92	37.2	43.67	177.21	614.92
Long-Term Leases	305.03	337.13	457.73	495.25	570.58
Long-Term Unearned Revenue	23.46	28.36	27.43	16.41	20.47
Long-Term Deferred Tax Liabilities	3.3	2.88	12.58	12.01	26.07
Other Long-Term Liabilities	16.44	5.47	5.24	5.02	5.81
Total Liabilities	732.59	757.75	973.44	1,438	2,229
Common Stock	497.96	497.96	499.78	499.78	499.78
Additional Paid-In Capital	1,260	1,205	1,229	1,229	1,229
Retained Earnings	-497.51	-510.92	-284.45	648.27	269.68
Treasury Stock	-	-	-25.51	-25.51	-20.44
Comprehensive Income & Other	15.99	21.33	17.64	9.81	-13.76
Total Common Equity	1,276	1,214	1,437	2,362	1,964
Minority Interest	24.34	24.2	24.24	24.43	24.63
Shareholders' Equity	1,300	1,238	1,461	2,386	1,989
Total Liabilities & Equity	2,033	1,996	2,434	3,824	4,218
Total Debt	469.17	513.31	635.34	966.2	1,747
Net Cash (Debt)	-11.78	-143.93	-285.88	-204.53	-1,568
Net Cash Per Share	-0.03	-0.29	-0.57	-0.41	-3.16
Filing Date Shares Outstanding	290.13	497.96	497.96	497.96	498.33
Total Common Shares Outstanding	290.13	497.96	497.96	497.96	498.33
Working Capital	409.57	297.37	300.4	548.33	-302.91
Book Value Per Share	4.40	2.44	2.89	4.74	3.94
Tangible Book Value	1,243	1,183	1,267	1,447	608.37
Tangible Book Value Per Share	4.29	2.38	2.55	2.91	1.22
Buildings	-	102.02	103.1	52.82	238.54
Machinery	-	533.18	554.12	464.19	791.09
Construction In Progress	-	13	7.96	75.36	235.74